Nova Eye Medical Limited (ASX:EYE)
Australia · Delayed Price · Currency is AUD 0.1400
+0.0050 (3.70%)
Sep 17, 2026, 3:53 PM AEST
Nova Eye Medical Revenue
In the fiscal year ending June 30, 2026, Nova Eye Medical had annual revenue of 34.87M AUD with 19.13% growth. Nova Eye Medical had revenue of 18.15M in the half year ending June 30, 2026, with 37.67% growth.
Revenue
34.87M
Revenue Growth
+19.13%
P/S Ratio
1.10
Revenue / Employee
115.83K
Employees
301
Market Cap
38.46M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 34.87M | 5.60M | 19.13% |
| Jun 30, 2025 | 29.27M | 5.94M | 25.47% |
| Jun 30, 2024 | 23.33M | 6.30M | 37.00% |
| Jun 30, 2023 | 17.03M | 3.65M | 27.26% |
| Jun 30, 2022 | 13.38M | -16.00K | -0.12% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| SomnoMed | 114.53M |
| Compumedics | 61.88M |
| Cyclopharm | 34.42M |
| CleanSpace Holdings | 19.82M |
| ImpediMed | 14.61M |
| OncoSil Medical | 5.09M |
| Control Bionics | 4.77M |
| Epiminder | 2.13M |